Breast Cancer
Dr. Timothy Yap discusses the PETRA trial, which showed the efficacy of saruparib in treating HER2-negative breast cancer.
Soft tumor environments can cause triple-negative breast cancer to spread more aggressively.
Patients ≥70 years of age were more likely to have a reduction in their palbociclib dosage.
Decreasing the at-home dose of dexamethasone before paclitaxel treatment may help reduce the incidence of infusion reactions.
Dr. Samilia Obeng-Gyasi discusses how social factors can impact outcomes in breast cancer patients.
For women with BRCA1 sequence variations, MRI surveillance is linked to lower breast cancer mortality.
A study found a "substantial deficit" of undiagnosed cancer cases during the COVID-19 pandemic.
Completing HBOT appears effective at reducing pain and fibrosis in patients with irradiated breast cancer.
A researcher is looking to prove that nebivolol, an FDA-approved drug for high blood pressure, is effective at treating TNBC.
Screening and new treatments have led to a US breast cancer mortality rate that is 58% lower than in it was in the mid-1970s.
Advertisement
Expert Interviews on Oncology
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
